Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 70

1.

[The impact of oxygen tension in physiological regulation of human multipotent mesenchymal stromal cell functions].

Buravkova LB, Andreeva ER, Grigor'ev AI.

Fiziol Cheloveka. 2012 Jul-Aug;38(4):121-30. Review. Russian.

PMID:
23101375
2.

[Paracrine activity of multipotent mesenchymal stromal cells and its modulation at hypoxia].

andreeva ER, Buravkova LB.

Fiziol Cheloveka. 2013 May-Jun;39(3):104-13. Review. Russian.

PMID:
23885559
3.

[Multipotent mesenchymal stromal and immune cells interaction: reciprocal effects].

Andreeva ER, Buravkova LB.

Ross Fiziol Zh Im I M Sechenova. 2012 Dec;98(12):1441-59. Review. Russian.

PMID:
23461191
4.

Clonal composition of human multipotent mesenchymal stromal cells.

Bigildeev AE, Zhironkina OA, Shipounova IN, Sats NV, Kotyashova SY, Drize NI.

Exp Hematol. 2012 Oct;40(10):847-56.e4. doi: 10.1016/j.exphem.2012.06.006. Epub 2012 Jun 19.

PMID:
22728032
5.

Immunosuppressive effects of multipotent mesenchymal stromal cells in cultures with different O2 content in the medium.

Gornostaeva AN, Andreeva ER, Andrianova IV, Buravkova LB.

Bull Exp Biol Med. 2011 Aug;151(4):526-9.

PMID:
22448382
6.

Low ATP level is sufficient to maintain the uncommitted state of multipotent mesenchymal stem cells.

Buravkova LB, Rylova YV, Andreeva ER, Kulikov AV, Pogodina MV, Zhivotovsky B, Gogvadze V.

Biochim Biophys Acta. 2013 Oct;1830(10):4418-25. doi: 10.1016/j.bbagen.2013.05.029. Epub 2013 Jun 4.

PMID:
23742825
7.

[Interaction of human multipotential mesenchymal stromal and immune cells].

Buravkova LB, Andreeva ER.

Fiziol Cheloveka. 2010 Sep-Oct;36(5):110-20. Review. Russian.

PMID:
21061676
8.

[Alteration of MMSC's immunosupression at reduced o2: direct cell-to-cell contacts and paracrine regulation].

Gornostaeva AN, Andreeva ER, Buravkova LB.

Fiziol Cheloveka. 2013 Mar-Apr;39(2):31-42. Russian.

PMID:
23789383
9.

[Oxidative stress resistance of multipotent mesenchymal stromal cells cultivated under different oxygen tension].

Pogodina MV, Buravkova LB.

Aviakosm Ekolog Med. 2014;48(6):34-8. Russian.

PMID:
25928982
10.

Therapeutic applications of mesenchymal stromal cells: paracrine effects and potential improvements.

Doorn J, Moll G, Le Blanc K, van Blitterswijk C, de Boer J.

Tissue Eng Part B Rev. 2012 Apr;18(2):101-15. doi: 10.1089/ten.TEB.2011.0488. Epub 2011 Dec 22. Review.

PMID:
21995703
11.

Uraemia disrupts the vascular niche in a 3D co-culture system of human mesenchymal stem cells and endothelial cells.

Kramann R, Couson SK, Neuss S, Floege J, Knüchel R, Schneider RK.

Nephrol Dial Transplant. 2012 Jul;27(7):2693-702. doi: 10.1093/ndt/gfr656. Epub 2011 Dec 29.

PMID:
22207324
12.

Mesenchymal stem cells: a perspective from in vitro cultures to in vivo migration and niches.

Augello A, Kurth TB, De Bari C.

Eur Cell Mater. 2010 Sep 1;20:121-33. Review.

13.

[Long-term expansion of multipotent mesenchymal stromal cells under reduced oxygen tension].

Rylova IuV, Buravkova LB.

Tsitologiia. 2013;55(12):852-60. Russian.

PMID:
25474903
14.

[Localization and functions of mesenchymal stromal cells in vivo].

Payushina V.

Zh Obshch Biol. 2015 Mar-Apr;76(2):161-72. Review. Russian.

PMID:
25985489
15.

Neuronal plasticity of human Wharton's jelly mesenchymal stromal cells to the dopaminergic cell type compared with human bone marrow mesenchymal stromal cells.

Datta I, Mishra S, Mohanty L, Pulikkot S, Joshi PG.

Cytotherapy. 2011 Sep;13(8):918-32. doi: 10.3109/14653249.2011.579957. Epub 2011 Jun 22.

PMID:
21696238
16.

Low physiologic oxygen tensions reduce proliferation and differentiation of human multipotent mesenchymal stromal cells.

Holzwarth C, Vaegler M, Gieseke F, Pfister SM, Handgretinger R, Kerst G, Müller I.

BMC Cell Biol. 2010 Jan 28;11:11. doi: 10.1186/1471-2121-11-11.

17.

[Hypoxic stress as a trigger of multipotent mesenchymal stromal cell activation].

Andreeva ER, Pogodina MV, Buravkova LB.

Fiziol Cheloveka. 2015 Mar-Apr;41(2):123-9. Review. Russian.

PMID:
26027343
18.

Mesenchymal stromal cell therapy: a revolution in Regenerative Medicine?

Bernardo ME, Pagliara D, Locatelli F.

Bone Marrow Transplant. 2012 Feb;47(2):164-71. doi: 10.1038/bmt.2011.81. Epub 2011 Apr 11. Review.

PMID:
21478914
19.

Hypoxia and stem cell-based engineering of mesenchymal tissues.

Ma T, Grayson WL, Fröhlich M, Vunjak-Novakovic G.

Biotechnol Prog. 2009 Jan-Feb;25(1):32-42. doi: 10.1002/btpr.128. Review.

20.

Human inferior turbinate: an alternative tissue source of multipotent mesenchymal stromal cells.

Hwang SH, Kim SY, Park SH, Choi MY, Kang HW, Seol YJ, Park JH, Cho DW, Hong OK, Rha JG, Kim SW.

Otolaryngol Head Neck Surg. 2012 Sep;147(3):568-74. doi: 10.1177/0194599812447172. Epub 2012 May 15.

PMID:
22588732

Supplemental Content

Support Center